GridAI Technologies (GRDX) Payables (2015 - 2026)
GridAI Technologies' (GRDX) quarterly Payables came in at $5.8 million in Q2 2026, up 67.0% on a YoY basis from $3.5 million in Q2 2025, and down 18.07% quarter-over-quarter from $7.1 million in Q4 2025.
Analysis
GridAI Technologies (GRDX) Payables (2015 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Payables for 12 consecutive years, with $5.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Payables rose 67.0% year-over-year to $5.8 million; the trailing twelve-month figure through Jun 2026 stood at $5.8 million (up 67.0% YoY), and the FY2025 full-year result was $7.1 million, up 65.26% from the prior year.
- Payables retreated to $5.8 million in Q2 2026 per GRDX's latest filing, from $7.1 million in the prior quarter.
- Across five years, Payables topped out at $7.1 million in Q4 2025 and bottomed at $810338.0 in Q3 2023.
- Historically, Payables has averaged $3.4 million across 5 years, with a median of $3.5 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Payables sank 79.5% in 2022, then surged 196.64% in 2024.
- Over 5 years, Payables stood at $2.1 million in 2022, then advanced by 7.27% to $2.2 million in 2023, then jumped by 90.9% to $4.3 million in 2024, then surged by 65.26% to $7.1 million in 2025, then slipped by 18.07% to $5.8 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $5.8 million, $7.1 million, and $6.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.74 Bn | 192.75 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 179.96 Bn | 176.78 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 131.20 Bn | 123.35 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.05 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.08 Bn | 29.78 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 31.91 Bn | 30.62 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Roivant Sciences | 29.22 Bn | 29.22 Bn | 1.16 Mn | 25.08 Mn |
| 10 | GridAI Technologies | 18.97 Mn | 18.97 Mn | -36,514.00 | 5.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.78 Mn |
| Dec 31, 2025 | 7.06 Mn |
| Sep 30, 2025 | 6.54 Mn |
| Jun 30, 2025 | 3.46 Mn |
| Mar 31, 2025 | 4.24 Mn |
| Dec 31, 2024 | 4.27 Mn |
| Sep 30, 2024 | 2.40 Mn |
| Jun 30, 2024 | 2.30 Mn |
| Mar 31, 2024 | 2.45 Mn |
| Dec 31, 2023 | 2.24 Mn |
| Sep 30, 2023 | 810,338.00 |
| Jun 30, 2023 | 1.93 Mn |
| Mar 31, 2023 | 937,581.00 |
| Dec 31, 2022 | 2.09 Mn |
| Sep 30, 2022 | 3.88 Mn |
| Jun 30, 2022 | 4.32 Mn |
| Mar 31, 2022 | 3.94 Mn |
| Dec 31, 2021 | 3.81 Mn |
| Sep 30, 2021 | 18.93 Mn |
| Jun 30, 2021 | 5.01 Mn |